Category Archives: $SPSIBI

Biotech’s Bearish Condition

October 4, 2026 By in $SPSIBI, BBIO, SPBIO, Speck-Effect, The Speck, XBI, XBI-26-17 Leave a comment

Technical First

Depending on price action, the next several updates on XBI, will discuss the technical condition.

Then, we’ll get into behind-the-scenes or ‘fundamentals’.

With that said, we’ll start with the big picture, long timeframe; Fibonacci 8-Day

Biotech XBI, 8-Day

Price action has made it all the way back to 2021 manic highs, and stalled.

A potential double top.

Not present back in 2021, was the bearish (divergent) momentum condition highlighted by MACD histogram.

So, we have a potential double top, a terminating wedge and bearish MACD.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

S&P … Almost ‘There’

October 3, 2026 By in $SPSIBI, AZO, Biotech, BKNG, DUOL, HD, KMX, LOW, S&P, S&P 500, Semiconductors, SPBIO, Speck-Effect, SPY, The Speck, XBI, XBI-26-17 Leave a comment

‘There’, is a new All-Time High

Two weeks ago, was this update showing the (net) upward progress of the S&P was slowing (not advice, not a recommendation).

Then, two days later was this, presenting how the index might make it to another high.

Now, the SPY chart is mimicking the longer timeframe by having successive shorter thrusts (magenta arrows).

At this point it’s a toss-up but does it really matter?

Meaning, if the downside is being worked (shorted), large numbers of tickers are already in essentially free-fall: AZO, BKNG, DUOL, HD, KMX, LOW; way below their all-time highs (not advice, not a recommendation).

Note: All have been covered at some point, on this site.

One sector that’s not cracked (yet) but seems to be building up immense pressure, is biotech.

Barring any unforeseen event, XBI is covered next.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Using Volume Clues

October 1, 2026 By in $SPSIBI, Bert Dohmen, LABD, SPBIO Leave a comment

Leveraged Professionals

Leveraged funds, especially 3X biotech inverse fund LABD, is likely to weed out (bankrupt) an inexperienced participant in due time.

With that said, we have to at least concede there are some deep pocket professionals participating in the same fund during the same hours as our market neophytes.

So, when volume behaves in a way uncharacteristic to the market, something’s up … or about to be up.

Biotech 3X Leveraged Inverse Fund LABD, 1-minute.

The volume spike indicates capitulation or a big player has just moved in.

At the blue ‘arrow’, there are three one-minute bars.

The long entry took place during the second bar (not advice, not a recommendation).

The next chart shows the result.

As Bert Dohmen has said countless times during recent interviews, ‘Nobody looks at volume’.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Top … So, Far

September 29, 2026 By in $SPSIBI, Biotech, SPBIO, Up-Thrust, XBI, XBI-26-16 Leave a comment

Subdividing Lower

Looking at the chart from left-to-right, the peaks are lower and the lows, are lower.

As noted, today was an apparent up-thrust (reversal), with a test coming towards the close.

After-hours action (as of 7:40 p.m., EST) is holding steady; no movement up or down.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Axis of Biotech

September 28, 2026 By in Biotech, SPBIO, $SPSIBI, XBI, XBI-26-16 Leave a comment

Underside Test

The chart segment of XBI shows its posted an axis line over the past few months.

There have been oscillations on both sides, with today being an underside test.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Market Highs, Weeks, Months Ago

September 18, 2026 By in $SPSIBI, Artificial Intelligence, Biotech, DIA, Dow 30, House of El - AI, Nasdaq, Ox Talks, QQQ, S&P, S&P 500, Semiconductors, SOXX, SPY, XBI, XBI-26-11, XBI-26-12

Dow, S&P, Qs Et al.

The Dow (DIA) all-time highs were on August 5th, the S&P (SPY) on August 13th, the Qs (QQQ), way back on June 3rd; Semiconductors (SOXX), June 22nd, and the list goes on.

We have updates by the day, if not the hour, like this, this, and this, letting us know in real-time, the air’s coming out of the bubble (not advice, not a recommendation).

So, ‘gentlemen, start your engines‘ 🙂

Pick your market

Biotech XBI, Daily

The chart has an added bonus, showing the potential trading channel.

Trade Action: Yesterday, XBI-26-11, was exited at break even, then re-established (short) as XBI-26-12, and well-in-the-green by the close (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (channel) Breakdown

September 15, 2026 By in $SPSIBI, Biotech, IBB, IBB-26-05, SPBIO, XBI, XBI-26-11

Off The Cliff?

We won’t know for sure, until a long time from now … when it’s all over (not advice, not a recommendation).

Yesterday’s action in biotech IBB, posted a new daily high, while at the same time, XBI moved higher but was unable to post a new high.

Trade Action: IBB-26-05, was exited with profit and the short re-established as XBI-26-11 (not advice, not a recommendation).

As the chart shows (blue arrows), that XBI short was increased during today’s session.

Biotech XBI, Daily

We’re still at the far-right side, the ‘supply side’.

If the entire channel is in-effect, the ‘demand side’, is a long way away.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech in ‘Sequence’

September 11, 2026 By in $SPSIBI, Biotech, IBB, IBB-26-05, SPBIO

Fibonacci Sequence

As far as the markets are concerned, when ‘everybody’ figures out there’s a pattern going on, that pattern morphs into something else.

For now, as the chart shows, it looks like biotech IBB, is ‘respecting’ a Fibonacci sequence (not advice, not a recommendation).

The chart also shows a potential channel.

Biotech IBB, Daily

So far, IBB is pivoting right at, or adjacent to sequence numbers (not advice, not a recommendation).

Next up, would be number ’21’.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech follows Amgen … Down

September 8, 2026 By in $SPSIBI, AMGN, Biotech, IBB, IBB-26-05, SPBIO, XBI, XBI-26-10

IBB, Below Support

Amgen was whacked for a -10.08% loss during today’s session.

Biotech IBB, XBI, followed suit; down -2.17% and -1.15%, respectively.

Both indexes retraced during the day; it was noted XBI’s retrace was 50%, while IBB’s retrace as 38%.

Therefore, the trading response was to close short-trade XBI-26-10 (for profit), re-establish that short via IBB, as IBB-26-05 (not advice, not a recommendation).

Note in the chart above, the last time IBB pushed below support, it was in spring position and moved higher the next three sessions.

Markets tend to alternate.

Let’s see what happens next.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech at The Edge (again)

September 3, 2026 By in $SPSIBI, ABNB, Biotech, CVNA, KMX, LABD, LABD-26-10, SPBIO, XBI, XBI-26-10 1 Comment

Is The Top, In?

Whether it’s Biotech XBI, Airbnb, CarMax or Carvana, trade set-ups are being worked that take place at the ‘edge of congestion.’

The last update on XBI, was here, August 24th, nine trading days ago.

The short, LABD-26-10 was immediately stopped out at the next session.

The index labored on, grinding in a range while posting a bearish MACD divergence on daily and weekly.

All of which, brings us to now.

The chart shows today’s action could not close above the resistance area posted back in July (not advice, not a recommendation).

There’s been no new daily low (yet).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279